BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Akman M, Belisario DC, Salaroglio IC, Kopecka J, Donadelli M, De Smaele E, Riganti C. Hypoxia, endoplasmic reticulum stress and chemoresistance: dangerous liaisons. J Exp Clin Cancer Res 2021;40:28. [PMID: 33423689 DOI: 10.1186/s13046-020-01824-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Lan T, Ji N, Tian QQ, Zhan Y, He W. An edoplasmic reticulum-targeted NIR fluorescent probe with a large Stokes shift for hypoxia imaging. Spectrochim Acta A Mol Biomol Spectrosc 2023;288:122201. [PMID: 36463622 DOI: 10.1016/j.saa.2022.122201] [Reference Citation Analysis]
2 González-Ortiz A, Pulido-Capiz A, Castañeda-Sánchez CY, Ibarra-López E, Galindo-Hernández O, Calderón-Fernández MA, López-Cossio LY, Díaz-Molina R, Chimal-Vega B, Serafín-Higuera N, Córdova-Guerrero I, García-González V. eIF4A/PDCD4 Pathway, a Factor for Doxorubicin Chemoresistance in a Triple-Negative Breast Cancer Cell Model. Cells 2022;11. [PMID: 36552834 DOI: 10.3390/cells11244069] [Reference Citation Analysis]
3 Forgie BN, Prakash R, Telleria CM. Revisiting the Anti-Cancer Toxicity of Clinically Approved Platinating Derivatives. Int J Mol Sci 2022;23. [PMID: 36499737 DOI: 10.3390/ijms232315410] [Reference Citation Analysis]
4 Liguori F, Carradori S, Ronca R, Rezzola S, Filiberti S, Carta F, Turati M, Supuran CT. Benzenesulfonamides with different rigidity-conferring linkers as carbonic anhydrase inhibitors: an insight into the antiproliferative effect on glioblastoma, pancreatic, and breast cancer cells. J Enzyme Inhib Med Chem 2022;37:1857-69. [PMID: 35768159 DOI: 10.1080/14756366.2022.2091557] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Onuma T, Asare-werehene M, Yoshida Y, Tsang BK. Exosomal Plasma Gelsolin Is an Immunosuppressive Mediator in the Ovarian Tumor Microenvironment and a Determinant of Chemoresistance. Cells 2022;11:3305. [DOI: 10.3390/cells11203305] [Reference Citation Analysis]
6 Chen G, Wu K, Li H, Xia D, He T. Role of hypoxia in the tumor microenvironment and targeted therapy. Front Oncol 2022;12:961637. [DOI: 10.3389/fonc.2022.961637] [Reference Citation Analysis]
7 Kwon Y, Kim J, Cho S, Kang YJ, Hwang M, Lee J, Kwon J, Rhee H, Bauer S, Kim H, Lee E, Kim HS, Kim H, Kim WK. Identification of novel pathogenic roles of BLZF1/ATF6 in tumorigenesis of gastrointestinal stromal tumor mediated by Golgi-localized mutant KIT.. [DOI: 10.21203/rs.3.rs-2081674/v1] [Reference Citation Analysis]
8 Cai J, Ji Z, Wu J, Chen L, Zheng D, Chen Y, Zhang X, Xie W, Huang J, Chen M, Lin R, Lin W, Chen Y, Li Z. Development and validation of a novel endoplasmic reticulum stress-related lncRNA prognostic signature and candidate drugs in breast cancer. Front Genet 2022;13:949314. [DOI: 10.3389/fgene.2022.949314] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Wu H, Tang J, Sun J, Tian C, Li X, Zhong B, Ilmer M, Wang Z, Dong M, Sheng W. Calreticulin promotes EMT in pancreatic cancer by enhancing endoplasmic reticulum stress-induced autophagy.. [DOI: 10.21203/rs.3.rs-1963841/v1] [Reference Citation Analysis]
10 Salaroglio IC, Belisario DC, Akman M, La Vecchia S, Godel M, Anobile DP, Ortone G, Digiovanni S, Fontana S, Costamagna C, Rubinstein M, Kopecka J, Riganti C. Mitochondrial ROS drive resistance to chemotherapy and immune-killing in hypoxic non-small cell lung cancer. J Exp Clin Cancer Res 2022;41:243. [DOI: 10.1186/s13046-022-02447-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Luo Z, Tian M, Yang G, Tan Q, Chen Y, Li G, Zhang Q, Li Y, Wan P, Wu J. Hypoxia signaling in human health and diseases: implications and prospects for therapeutics. Signal Transduct Target Ther 2022;7:218. [PMID: 35798726 DOI: 10.1038/s41392-022-01080-1] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
12 Zheng Y, Yue X, Fang C, Jia Z, Chen Y, Xie H, Zhao J, Yang Z, Li L, Chen Z, Bian E, Zhao B. A Novel Defined Endoplasmic Reticulum Stress-Related lncRNA Signature for Prognosis Prediction and Immune Therapy in Glioma. Front Oncol 2022;12:930923. [DOI: 10.3389/fonc.2022.930923] [Reference Citation Analysis]
13 Yang C, Wei Y, Li W, Wei J, Chen G, Xu M, Liu G, Wang F. Prognostic Risk Signature and Comprehensive Analyses of Endoplasmic Reticulum Stress-Related Genes in Lung Adenocarcinoma. Journal of Immunology Research 2022;2022:1-39. [DOI: 10.1155/2022/6567916] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Qie S, Sang N. Stanniocalcin 2 (STC2): a universal tumour biomarker and a potential therapeutical target. J Exp Clin Cancer Res 2022;41:161. [PMID: 35501821 DOI: 10.1186/s13046-022-02370-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Zhang Q, Huang Z, Rui X, Wang Y, Wang Y, Zhou Y, Chen R, Chen Y, Wang Y, Li S, Li H, Shen X, Liang Y, Zhang Y, Huang Z. GSDMD enhances cisplatin-induced apoptosis by promoting the phosphorylation of eIF2α and activating the ER-stress response. Cell Death Discov 2022;8:114. [PMID: 35289335 DOI: 10.1038/s41420-022-00915-8] [Reference Citation Analysis]
16 Labrie M, Brugge JS, Mills GB, Zervantonakis IK. Therapy resistance: opportunities created by adaptive responses to targeted therapies in cancer. Nat Rev Cancer 2022. [PMID: 35264777 DOI: 10.1038/s41568-022-00454-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
17 Gowdhami B, Manojkumar Y, Vimala RTV, Ramya V, Karthiyayini B, Kadalmani B, Akbarsha MA. Cytotoxic cobalt (III) Schiff base complexes: in vitro anti-proliferative, oxidative stress and gene expression studies in human breast and lung cancer cells. Biometals 2021. [PMID: 34935092 DOI: 10.1007/s10534-021-00351-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
18 Tang P, Qu W, Wang T, Liu M, Wu D, Tan L, Zhou H. Identifying a Hypoxia-Related Long Non-Coding RNAs Signature to Improve the Prediction of Prognosis and Immunotherapy Response in Hepatocellular Carcinoma. Front Genet 2021;12:785185. [DOI: 10.3389/fgene.2021.785185] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
19 Kopecka J, Salaroglio IC, Perez-Ruiz E, Sarmento-Ribeiro AB, Saponara S, De Las Rivas J, Riganti C. Hypoxia as a driver of resistance to immunotherapy. Drug Resist Updat 2021;:100787. [PMID: 34840068 DOI: 10.1016/j.drup.2021.100787] [Cited by in Crossref: 11] [Cited by in F6Publishing: 17] [Article Influence: 5.5] [Reference Citation Analysis]
20 Tian X, Zhang S, Zhou L, Seyhan AA, Hernandez Borrero L, Zhang Y, El-Deiry WS. Targeting the Integrated Stress Response in Cancer Therapy. Front Pharmacol 2021;12:747837. [PMID: 34630117 DOI: 10.3389/fphar.2021.747837] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 9.5] [Reference Citation Analysis]
21 Maniam S, Maniam S. Small Molecules Targeting Programmed Cell Death in Breast Cancer Cells. Int J Mol Sci 2021;22:9722. [PMID: 34575883 DOI: 10.3390/ijms22189722] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Hattinger CM, Patrizio MP, Fantoni L, Casotti C, Riganti C, Serra M. Drug Resistance in Osteosarcoma: Emerging Biomarkers, Therapeutic Targets and Treatment Strategies. Cancers (Basel) 2021;13:2878. [PMID: 34207685 DOI: 10.3390/cancers13122878] [Cited by in Crossref: 20] [Cited by in F6Publishing: 28] [Article Influence: 10.0] [Reference Citation Analysis]
23 Reiter RJ, Sharma R, Rodriguez C, Martin V, Rosales-Corral S, Zuccari DAPC, Chuffa LGA. Part-time cancers and role of melatonin in determining their metabolic phenotype. Life Sci 2021;278:119597. [PMID: 33974932 DOI: 10.1016/j.lfs.2021.119597] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]